Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T12:57:56.788Z Has data issue: false hasContentIssue false
  • English
  • Français

Nicotine exposure during breastfeeding alters the expression of endocannabinoid system biomarkers in female but not in male offspring at adulthood

Published online by Cambridge University Press:  23 February 2023

Rosiane Aparecida Miranda ,
Vanessa Silva Tavares Rodrigues ,
Thamara Cherem Peixoto ,
Alex C. Manhães Open the ORCID record for Alex C. Manhães [Opens in a new window] ,
Egberto Gaspar de Moura Open the ORCID record for Egberto Gaspar de Moura [Opens in a new window]  and
Patricia Cristina Lisboa Open the ORCID record for Patricia Cristina Lisboa [Opens in a new window]
Rosiane Aparecida Miranda
Affiliation:
Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
Vanessa Silva Tavares Rodrigues
Affiliation:
Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
Thamara Cherem Peixoto
Affiliation:
Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
Alex C. Manhães
Affiliation:
Laboratory of Neurophysiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
Egberto Gaspar de Moura
Affiliation:
Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
Patricia Cristina Lisboa*
Affiliation:
Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, RJ, Brazil
*
Address for correspondence: Dr. Patrícia Cristina Lisboa, Physiological Sciences Department; Biology Institute, Rio de Janeiro State University, 28 DE Setembro Avenue, 87, Rio de Janeiro, RJ, 20551-031, Brazil. Email: pclisboa@uerj.br
Rights & Permissions [Opens in a new window]

Abstract

Early nicotine exposure compromises offspring’s phenotype at long-term in both sexes. We hypothesize that offspring exposed to nicotine during breastfeeding show deregulated central and peripheral endocannabinoid system (ECS), compromising several aspects of their metabolism. Lactating rats received nicotine (NIC, 6 mg/Kg/day) or saline from postnatal day (PND) 2 to 16 through implanted osmotic minipumps. Offspring were analyzed at PND180. We evaluated protein expression of N-acylphosphatidylethanolamide-phospholipase D (NAPE-PLD), fatty acid amide hydrolase (FAAH), diacylglycerol lipase (DAGL), monoacylglycerol lipase (MAGL) and cannabinoid receptors (CB1 and/or CB2) in lateral hypothalamus, paraventricular nucleus of the hypothalamus, liver, visceral adipose tissue (VAT), adrenal and thyroid. NIC offspring from both sexes did not show differences in hypothalamic ECS markers. Peripheral ECS markers showed no alterations in NIC males. In contrast, NIC females had lower liver DAGL and CB1, higher VAT DAGL, higher adrenal NAPE-PLD and higher thyroid FAAH. Endocannabinoids biosynthesis was affected by nicotine exposure during breastfeeding only in females; alterations in peripheral tissues suggest lower action in liver and higher action in VAT, adrenal and thyroid. Effects of nicotine exposure during lactation on ECS markers are sex- and tissue-dependent. This characterization helps understanding the phenotype of the adult offspring in this model and may contribute to the development of new pharmacological targets for the treatment of several metabolic diseases that originate during development.

Keywords

Nicotine exposureendocannabinoid systembreastfeedingadulthood

Information

Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 14 , Issue 3 , June 2023 , pp. 415 - 425
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press in association with International Society for Developmental Origins of Health and Disease

Introduction

Mammals are particularly vulnerable to environmental changes during the lactation period that could induce neuroendocrine adaptations and compromise health at adulthood. The “Development Origins of Health and Diseases” (DOHaD) hypothesis aims to explain the impact of environmental changes during early life stages. Reference Barker1 Chemicals and drugs exposures are important factors that are capable of programming the progeny to a deregulated metabolism in later life. Reference Haugen, Schug, Collman and Heindel2 As an example, nicotine, the major addictive compound present in cigarette smoke, has already been described as a chemical disruptor that changes milk supply and composition, Reference Bahadori, Riediger, Farrell, Uitz and Moghadasian3,Reference Horta, Victora, Menezes and Barros4 affecting the baby’s health at short and long term. Reference Napierala, Mazela, Merritt and Florek5,Reference Somm, Schwitzgebel and Vauthay6 Nicotine is an important emerging pollutant that can be found on surfaces, Reference Marcham, Floyd, Wood, Arnold and Johnson7 water, Reference Anastopoulos, Pashalidis and Orfanos8 soil, air Reference Selmar, Radwan and Abdalla9 and even in pregnant woman’s hair. Reference Li, Li and Zhang10 We have previously demonstrated that maternal nicotine exposure during lactation compromises rat offspring’s phenotype at long-term in a sex-dependent manner: male offspring showed, at adulthood, obesity, normophagia, despite hypothalamic leptin resistance, hyperleptinemia, hypercorticosteronemia and hypothyroidism, while female offspring had normal body mass, despite hyperphagia, unchanged leptinemia and corticosteronemia, but hyperthyroidism. Reference Miranda, Gaspar de Moura and Lisboa11-Reference Peixoto, Moura and Soares13

Several different mechanisms have been associated with endocrine dysfunctions, some of which have been linked to obesity onset. Studies have already described an interaction of a disturbed endocannabinoid system (ECS) with endocrine system changes and obesity. Reference Hillard14-Reference Zdanowicz, Kazmierczak and Wierzbinski16 The ECS acts in many physiological processes, both in the central nervous system (CNS) Reference Hu and Mackie17 and in peripheral tissues, Reference Ruminska and Dobrzyn18 via signaling pathways that depend on enzymatic machinery. The endogenous cannabinoids N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) are derived from membrane phospholipids and are synthesized by the enzymes N-acylphosphatidylethanolamine-phospholipase D (NAPE-PLD) and diacylglycerol lipase (DAGL), respectively. Reference Zou and Kumar19 The endocannabinoids act via two G protein-coupled receptors: the cannabinoid receptor type-1 (CB1) and the cannabinoid receptor type-2 (CB2). Reference Howlett, Barth and Bonner20 Once utilized by the cells, AEA is degraded by the fatty acid amide hydrolase (FAAH) and the 2-AG is degraded by the monoacylglycerol lipase (MAGL). Reference Kilaru and Chapman21 In the CNS, endocannabinoids activity was shown to affect levels of anxiety and depression, neurogenesis, reward, cognition, learning, memory and food intake. Reference Mechoulam and Parker22,Reference Quarta, Mazza, Obici, Pasquali and Pagotto23 In the lateral hypothalamus (LH), ECS activation increases food intake Reference Sanchez-Fuentes, Marichal-Cancino, Mendez-Diaz, Becerril-Melendez, Ruiz-Contreras and Prospero-Garcia24 and reduces energy expenditure. Reference Richard, Guesdon and Timofeeva25 In the paraventricular nucleus (PVN), besides modulating energy expenditure, Reference Peterfi, Farkas and Denis26 endocannabinoids also seem to be involved in neuroendocrine processes, such as the inhibitory effect on the negative feedback of glucocorticoids on corticotropin-releasing hormone (CRH) secretion. Reference Barna, Zelena, Arszovszki and Ledent27 In the liver, endocannabinoids increase lipid accumulation and reactive oxygen species. Reference Wang, Meng, Chang and Tang28 In the white adipose tissue, they are involved in increasing production and storage of triglycerides, reduction of adiponectin synthesis, and mitochondrial biogenesis. Reference Silvestri, Ligresti and Di Marzo29 In the adrenal gland, ECS influences adrenocortical steroidogenesis Reference Ziegler, Mohn and Lamounier-Zepter30 and suppresses adrenalin release from adrenal medullary cells, Reference Niederhoffer, Hansen, Fernandez-Ruiz and Szabo31 while, in the thyroid gland, it inhibits thyroid hormone release. Reference Porcella, Marchese and Casu32

Some studies have shown that the ECS modulates the addictive and rewarding properties of nicotine. Reference Merritt, Martin, Walters, Lichtman and Damaj33-Reference Castane, Valjent, Ledent, Parmentier, Maldonado and Valverde35 However, to our knowledge, the literature does not report data regarding the effects of nicotine exposure during the lactation period on the ECS of experimental models of metabolic programming. Due to the fact that the ECS modulates energy homeostasis and many endocrine functions, we hypothesize that the dysfunctions previously characterized in the offspring of our experimental model of metabolic programming by maternal nicotine exposure during breastfeeding is associated with a disrupted ECS in the CNS and in of peripheral tissues, such as liver, adipose tissue, adrenal and thyroid glands.

Material and Methods

Ethics approval

The Ethical Committee for Use of Laboratory Animals of the Biology Institute, Rio de Janeiro State University (CEUA/033/2017) has approved all experimental procedures. All animals were housed under controlled conditions in a 12-h light-dark cycle (lights on from 7 a.m. to 7 p.m.) and at a temperature of 21 ± 2°C throughout the experiment. Water and standard rodent chow diet (Nuvilab®, São Paulo, Brazil) were offered ad libitum. We performed the experiments in accordance to the American Physiological Society’s guiding principles.

Animals and nicotine exposure

Female and male Wistar rats were mated at 3 months old. After detection of pregnancy, pregnant rats were housed in individual cages. At birth, all litters were normalized to six pups per litter. At postnatal day (PND) 2, 14 lactating rat dams were randomly assigned to one of the following groups:

I) Nicotine (NIC, n = 7): dams were anesthetized with thiopental, a 3 × 6 cm area on the back was shaved and an incision was made to insert an osmotic minipump (OMP, Alzet, 2ML2, Los Angeles, CA, USA) subcutaneously. OMPs were prepared with nicotine free-base (Sigma, St Louis, MO, USA) diluted in NaCl 0.9% to release a dose of 6 mg/kg of nicotine/day from the PND2 to PND16, as previously described Reference Oliveira, Moura and Santos-Silva37 ;

II) Control (n = 7): dams were implanted with OMPs containing NaCl 0.9%.

The nicotine exposure via s.c. OMP avoids the adverse effects of nicotine peaks. In this rat model, the regimen of maternal nicotine exposure results in a total exposure of 84 mg/kg in 14 days per dam, which approximates cotinine levels of heavy human smokers. Reference Ypsilantis, Politou, Anagnostopoulos, Kortsaris and Simopoulos38 The period of 14 days of exposure during lactation corresponds to approximately 3–4 months of maternal smoking during breastfeeding in humans. Offspring were exposed to nicotine exclusively via milk and, at weaning, the pup’s blood cotinine was 20 ng/mL. Reference de Oliveira, Moura and Santos-Silva39

Offspring, at PND180, from both sexes, were weighed and anesthetized with thiopental (i.p. 150 mg/kg of body mass) and euthanized by cardiac puncture. Brain, liver, VAT, adrenal and thyroid glands were collected, immediately frozen in liquid nitrogen and stored at −80°C for analyses.

Punch technique

Coronal brain sections were cut using a cryostat (Hyrax C25, Zeiss, Germany) and punches of the lateral hypothalamus (LH, bregma 2.04 to 3.60 mm) and the paraventricular nucleus of hypothalamus (PVN, bregma 0.6 to −2.1 mm) were extracted according to Paxinos and Watson stereotaxic coordinate atlas. Reference Paxinos and Charles40 The cut thickness was approximately 1500 μm for both nuclei (variations in this parameter occurred as a function of sex, age, and size of the animals).

Western blotting

Frozen tissues were macerated in a specific extract buffer containing a protease inhibitor cocktail (S8830, SIGMAFAST™, Sigma-Aldrich, St Louis, MO, USA). The LH and PVN punches were sonicated twice in an ultrasonic processor for 10 s (15 s interval, 40% amplitude). Liver, VAT, adrenal and thyroid tissues were centrifuged at 17,004 × g for 15 min, 12,851 × g for 30 min, 10,621 × g for 5 min and 15,294 × g for 20 min at 4°C (Eppendorf 5417R, Hampton, USA), respectively. Total protein content was determined using a BCA™ Protein Assay Kit (Thermo Scientific®, Rockford, IL, USA). All samples were treated with Laemmli sample buffer (w/v: glycerol 30%; β-mercaptoethanol 20%; sodium dodecyl sulfate (SDS) 8%, 0.25 M Tris at pH 6.8 and bromophenol blue). Total protein extracts (15∼20 µg) were separated by 10% SDS-PAGE at 200 V for approximately 50 min. The proteins were then transferred from the gel to a polyvinylidene difluoride (PVDF) membranes using the Trans-Blot® turbo system (Bio-Rad® Laboratories, Hercules, CA, USA) and blocked with 5% BSA in Tween-Tris-buffered saline (TTBS; Tris-HCl, 1 mol/L; NaCl, 5 mol/L; and Tween 20, 0.05%, v/v) for 90 min under continuous shaking. Membranes were incubated overnight with the primary antibodies described in Table 1. PVDF filters were washed 3 times with Tween–TBS (0.1%), followed by 1 h incubation with appropriate biotin-conjugated secondary antibody (Table 1). Then, membranes were incubated with streptavidin-conjugated HRP (RPN1231V; Sigma-Aldrich, St Louis, MO, USA). Immunoreactive proteins were visualized with an ECL kit using an Image Quant LAS (Bio-Rad® Laboratories, Hercules, CA, USA). Bands were quantified by densitometry using Image J 1.4 software (Wayne Rasband, National Institutes of Health, Bethesda, MA, USA). Protein contents of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the LH and PVN, as well as cyclophilin B in the liver, VAT, adrenal and thyroid, were used as loading controls.

Table 1.

Antibodies used in western blotting

CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; DAGL-α: diacylglycerol lipase alpha; FAAH: fatty acid amide hydrolase; GAPDH: glyceraldehyde-3-phosphate 5 dehydrogenase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Statistical analyses

Data are expressed as mean ± standard error of the mean and were analyzed with the statistical program GraphPad Prism 6.0 (San Diego, CA, USA). Each variable was analyzed using two-way ANOVA with group and sex as between-subject factors (Table 2). Considering that, for the Western blotting analyses, males and females were assessed in different gels, the results in the graphs were analyzed separated by sex using Student’s t-tests (Control vs. NIC) for each protein. Differences were considered significant when p < 0.05. Effect size data is provided as Eta-squared (η2: small > 0.1, medium > 0.3, large > 0.5).

Table 2.

ANOVA results regarding nicotine exposure during lactation on endocannabinoid system of the adult offspring

CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; DAGL-α: diacylglycerol lipase alpha; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Results

NIC males showed a significant increase in body mass (595 ± 15 g) when compared to control males (520 ± 10 g), while NIC females showed no difference (NIC: 300 ± 8 vs. CON: 295 ± 10 g) when compared to control females. This finding agrees with findings of our previous studies. Reference Miranda, Gaspar de Moura and Lisboa11-Reference Peixoto, Moura and Soares13

ECS markers in the lateral hypothalamus (LH) and paraventricular nucleus (PVN)

As shown in Fig. 1, the protein levels of the ECS markers in the LH were not affected by nicotine exposure in both male (Fig. 1 a and 1 b) and female offspring (Fig. 1 c and 1 d).

Fig. 1.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the lateral hypothalamus (LH) of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). GAPDH was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. CB1: cannabinoid type-1 receptor; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; GAPDH: glyceraldehyde-3-phosphate 5 dehydrogenase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

We did not observe significant differences between groups in the parameters of the ECS in the PVN in both male (Fig. 2 a and 2 b) and female offspring (Fig. 2 c and 2 d). In both nuclei, the ANOVAs failed to identify interactions between early nicotine exposure and sex (Table 2).

Fig. 2.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the paraventricular nucleus (PVN) of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). GAPDH was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. CB1: cannabinoid type-1 receptor; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; GAPDH: glyceraldehyde-3-phosphate 5 dehydrogenase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

ECS markers in the liver

No significant differences were observed between groups in the ECS biomarkers of the male offspring (Fig. 3 a and 3 b). In contrast, NIC females had significantly lower DAGL (−44%, p = 0.012, η2 = 0.450) and CB1 protein levels (−40%, p = 0.028, η2 = 0.396) in the liver (Fig. 3 c and 3 d) in comparison with controls. No interactions between early nicotine exposure and sex were observed (Table 2).

Fig. 3.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the liver of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group, except for NAPE-PLD from males, n = 5 animals from different litters/group. Differences are represented by *, considering p < 0.05, (Student’s t-test); *p = 0.012 (DAGL) and *p = 0.028 (CB1). CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

ECS markers in the visceral adipose tissue (VAT)

NIC males did not show any alteration in ECS markers (Fig. 4 a and 4 b) in the VAT when compared to control males. Conversely, NIC females showed a significant increase in DAGL protein level (2.6-fold, p = 0.002, η2 = 0.611) (Fig. 4 c and 4 d ) in this tissue, in line with the observation of a significant interaction between Sex and Group for this marker (Table 2).

Fig. 4.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the visceral adipose tissue (VAT) of male (a) and female (c) offspring at PND180-day-old. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Differences are represented by **, considering p < 0.01 (Student’s t-test); p = 0.002. CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

ECS markers in the adrenal glands

Nicotine exposure during breastfeeding did not program the ECS markers in adrenal glands of male offspring (Fig 5 a and 5 b). Conversely, NIC females had a significant increase in NAPE-PLD protein level (2.5-fold, p = 0.026, η2 = 0.438) in the adrenal glands (Fig. 5 c and 5 d), a result compatible with the significant Sex × Group interaction for this marker (Table 2).

Fig. 5.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the adrenal glands of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Statistical differences are represented by *, considering p < 0.05 (Student’s t-test); p = 0.026. CB1: cannabinoid type-1 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

ECS markers in the thyroid gland

NIC males showed no changes in ECS markers when compared to control males (Fig 6 a and 6 b). Only NIC females showed an increased FAAH protein level (2.3-fold, p = 0.006, η2 = 0.586) in the thyroid gland (Fig. 6 c and 6 d), corroborating the Sex × Group interaction that was observed for this marker (Table 2).

Fig. 6.

Effects of nicotine exposure during breastfeeding on the endocannabinoid system in thyroid glands of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Statistical differences are represented by **, considering p < 0.01 (Student’s t-test); p = 0.006. CB1: cannabinoid type-1 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Discussion

In this study, for the first time, we characterized the ECS in different tissues in a programming model of nicotine exposure during breastfeeding. The ECS has a relevant role in the modulation of energy expenditure and in many physiological processes. Our main findings demonstrate that the major ECS markers were not affected in the LH and PNV nuclei of both male and female NIC offspring. Conversely, ECS markers of NIC females seem to be more affected in the peripheral tissues, since we characterized significantly lower protein expression of the biomarkers of ECS synthesis and action in the liver, higher DAGL expression (marker for 2-AG production) in the VAT, higher NAPE-PLD expression (marker for AEA synthesis marker) in the adrenal gland and higher FAAH expression (a marker of AEA degradation) in the thyroid gland.

Endocannabinoids are directly related to obesity onset. Several studies have demonstrated that the permanent overstimulation of the ECS, mainly in the CNS, contributes to the obese status. Reference Zdanowicz, Kazmierczak and Wierzbinski16,Reference Pagotto, Vicennati and Pasquali41,Reference Mazier, Saucisse, Gatta-Cherifi and Cota42 In our experimental model, NIC male offspring were imprinted to an obese phenotype at adulthood. It is therefore conceivable that the nicotine exposure during breastfeeding has modulated the offspring ECS. Indeed, the ECS was impaired in the CNS, specifically in dorsolateral striatum region, of adult Wistar rats that were exposed to nicotine, even after a long period of nicotine withdrawal. Reference Adermark, Morud, Lotfi, Ericson and Soderpalm43 Although this study did not evaluate the metabolic programming model or the same tissues that were assessed here, we suggest that an early nicotine exposure, during a phase of great CNS vulnerability, is capable of affecting the ECS at adulthood by imprinting a disruption of its activity. Interestingly, the imprinting process seems to be sex-dependent since only females showed marked effects.

Regarding the specific regions in the CNS in which the ECS plays important roles, such as the regulation of food intake, control of energy expenditure and neuroendocrine processes, Reference Sanchez-Fuentes, Marichal-Cancino, Mendez-Diaz, Becerril-Melendez, Ruiz-Contreras and Prospero-Garcia24,Reference Peterfi, Farkas and Denis26,Reference Barna, Zelena, Arszovszki and Ledent27 both the LH and the PVN must be highlighted. In the current study, we did not observe changes in ECS markers in the LH of both male and female offspring. This result is compatible with NIC males normophagia but not with females hyperphagia, as shown in our previous results, Reference Pinheiro, Oliveira and Trevenzoli44 which indicates that the endocannabinoid pathway did not contribute to this female phenotype. Other pathways, involving dopaminergic tonus or central leptin resistance, may explain this hyperphagia in NIC females. Reference Peixoto, Moura and Soares13 In the PVN, we did not observe changes in ECS markers in the offspring of either sex. ECS function could be associated with the regulation of glucocorticoid negative feedback in the PVN since NIC male offspring exhibit higher corticotropin-releasing hormone (CRH), higher adrenocorticotropic hormone and hypercorticosteronemia, as previously demonstrated by our group. Reference Pinheiro, Oliveira and Trevenzoli44 In the PVN, the feedback mechanism is mediated by a non-genomic corticosterone binding to glucocorticoid receptor and involves the endocannabinoid synthesis. Reference Di, Malcher-Lopes, Halmos and Tasker45 In addition, pharmacological inhibition of CB1 receptors results in increased corticosterone concentrations in male and female Wistar rats. Reference Roberts, Stuhr, Hutz, Raff and Hillard46 Similarly, the endocannabinoid system also acts in the inhibition of thyrotropin-releasing hormone (TRH) release, as indicated by an experiment that blocked CB1 receptors with an antagonist and observed, as a result, an increased TRH release in mouse median eminence explants. Reference Farkas, Varga and Kovacs47

The deregulation of the ECS does not occur only at a central level, but also in the periphery. Obese people show both central and peripheral ECS increases. Reference Pagotto, Vicennati and Pasquali41 Moreover, a deregulated ECS can be involved in other diseases. In the liver, for example, an upregulation of CB1 is related with hepatic fibrosis, steatosis, oxidative stress and lipid accumulation. Reference Osei-Hyiaman, DePetrillo and Pacher48-Reference Miranda, De Almeida and Rocha50 Our group has already demonstrated that NIC males have increased lipid accumulation, oxidative stress and steatosis. Reference Conceicao, Peixoto-Silva, Pinheiro, Oliveira, Moura and Lisboa51 However, these dysfunctions in our male experimental model apparently are independent of the ECS function, since ECS tonus was unaltered. In contrast, NIC females had a reduction of DAGL and CB1 receptor in the liver, which may help to protect this tissue from the harmful effects of ECS overstimulation, since NIC females have unchanged hepatic cytoarchitecture, as we have previously shown. Reference Bertasso, Pietrobon and Lopes52 It is possible that a compensatory effect is improving liver function by a mechanism remains to be determined.

The ECS also acts in the white adipose tissue stimulating lipogenesis and adipogenesis. Reference van Eenige, van der Stelt, Rensen and Kooijman53 In the VAT, NIC males did not show changes in ECS markers, while females had higher DAGL. In most cases, the deregulation of ECS is characterized by their overactivation. Reference Di Marzo54 The increase in the biosynthetic enzyme DAGL in the female offspring VAT suggests an increased 2-AG synthesis, which could be related with the higher adipocyte area as well as with the increased protein content of acetyl-CoA carboxylase and transcription factor CCAAT/enhancer-binding protein (C/EBP) beta that were previously observed in these animals. Reference Peixoto, Moura and Soares55 It is also known that increased 2-AG biosynthesis is involved in pro-inflammatory and prostaglandin responses, mainly because it serves as substrate for cyclooxygenases. Reference Janssen and van der Stelt56,Reference Rouzer and Marnett57

Concerning the ECS in the adrenal gland, NIC males did not show any changes, while NIC females had higher NAPE-PLD, which could indicate higher AEA synthesis. However, it is important to highlight that bioactive N-acylethanolamines, including AEA, can be formed from N-acylated plasmalogen through a NAPE-PLD-independent pathway. Reference Tsuboi, Okamoto and Ikematsu58 Our research group has already described the effects of nicotine exposure during lactation on the adrenal function of the offspring. We observed that males had higher adrenal catecholamine content, but lower in vitro catecholamine release, Reference Pinheiro, Oliveira and Trevenzoli44 while females had normal adrenal function. Reference Peixoto, Moura and Soares55 Endocannabinoids have an inhibitory effect on adrenaline secretion, as demonstrated by the administration of cannabinoids in isolated rabbit adrenal glands. Reference Niederhoffer, Hansen, Fernandez-Ruiz and Szabo31 In the adrenocortical cell line NCI-H295R, it was demonstrated that AEA is capable of inhibiting steroidogenesis. Reference Ziegler, Mohn and Lamounier-Zepter30 Furthermore, the administration of CB1 antagonist AM251 was shown to increase corticosterone levels in the adrenal cortex. Reference Newsom, Garcia and Stafford59 Contrasting with the unaltered expression of adrenal CB1 in our model, Surkin and Gallino Reference Surkin, Gallino, Luce, Correa, Fernandez-Solari and De Laurentiis60 suggest that, in the adrenal cortex, AEA has a potent effect via the vanilloid transient receptor potential cation channel subfamily V member 1 (TRPV1 receptors), which was not evaluated here. It is important to highlight that endocannabinoid stress modulation could be bidirectional: stress could alter the ECS activity as well as the ECS activity could induce alterations in HPA axis function.

The ECS is also present in the thyroid gland. Reference Porcella, Marchese and Casu32 Studies suggest that endocannabinoids have a negative regulation on TSH, T3 and T4 secretions. Reference Porcella, Marchese and Casu32,Reference Borowska, Czarnywojtek and Sawicka-Gutaj61,Reference da Veiga, Fonseca Bloise and Costa62 In addition, FAAH knockout mice had significant TSH, T3 and T4 reductions. Reference Brown, Gillum and Lee63 In a previous work, we demonstrated that NIC males showed low TSH, T3 and T4 plasma levels, while NIC females had higher T3 and T4. Reference Miranda, de Moura and Soares12 Here, NIC males did not show changes in thyroid ECS markers, but NIC females had higher thyroid FAAH protein expression. We can speculate that the overexpression of FAAH may avoid the accumulation of AEA and prevent its inhibitory effect on thyroid hormones secretion in females.

Regarding sex dimorphism, there is evidence in the literature that the ECS show sex-related differences. For instance, females seem to have lower activation of ECS than males. Reference Roberts, Stuhr, Hutz, Raff and Hillard46,Reference Riebe, Hill, Lee, Hillard and Gorzalka64 Considering other programming models, studies reported differences in ECS between sexes. Reference Miranda, De Almeida and Rocha50,Reference Almeida, Dias-Rocha and Souza65-Reference Moussa-Tooks, Larson and Gimeno67 Here, comparing male and female offspring, the differences observed in ECS markers could have the involvement of the sex hormones. We have already assessed estrogen and testosterone plasma levels in the neonatal nicotine exposure model: NIC females showed no alterations in estradiol and testosterone levels, while NIC males had lower testosterone without changes in estradiol. Reference Miranda, de Moura and Soares12 In the present study, only NIC females were affected. Thus, the protective effect mediated by estrogens Reference Carrillo, Collado, Diaz, Chowen, Perez-Izquierdo and Pinos68 did not occur regarding the ECS markers. We have previously detected, in a different experimental model, that adult female rats that were programmed by maternal cigarette smoke during lactation showed lower estradiol levels, higher hypothalamic DAGL protein expression, lower hepatic DALG and lower VAT CB1. Reference Soares, Miranda and Peixoto69 Thus, the late effects of nicotine exposure during lactation in the ECS of the female progeny differ from the effects observed in females exposed to cigarette smoke for the same period, suggesting that other compounds in the cigarette can also affect ECS tonus. However, in both models (nicotine and smoke), nicotine appears to be responsible for the reduction of DAGL in the liver. We summarize in Fig. 7, the ECS biosynthesis and degradation pathways, the main effects of the endocannabinoids in different tissues and the ECS markers in our experimental model.

Fig. 7.

The first panel (a) depicts the main proteins involved in endocannabinoid synthesis and degradation pathways. Phosphatidylethanolamine (PE) is converted to N-acylphosphatidylethanolamine (NAPE), catalyzed by the NAPE-phospholipase D (NAPE-PLD), producing anandamide (AEA). In addition, phosphatidylinositol (PI) is hydrolyzed by phospholipase C (PLC), originating diacylglycerol (DAG), which is converted to 2-arachidonoylglycerol (2-AG) by diacylglycerol lipase (DAGL). The endocannabinoids AEA and 2-AG act by binding to both type-1 or type-2 cannabinoid receptors (CB1 or CB2). The degradation of the endocannabinoids is mediated by fatty acid amide hydrolase (FAAH), which is responsible for AEA degradation, and by monoacylglycerol lipase (MAGL), which is responsible for 2-AG degradation. The metabolites of AEA and 2-AG are the arachidonic acid (AA) and ethanolamine, and AA and glycerol, respectively. The second panel (b) shows the main effects of the endocannabinoids in different tissues. The third panel (c) describes the ECS markers in adult rats that were nicotine-exposed during breastfeeding. OMP: osmotic minipumps.

Constitute limitations of our study the lack of measurement of AEA and 2-AG levels and of the activity of the enzymes involved in endocannabinoids metabolism.

In conclusion, we demonstrated that nicotine exposure during lactation imprinted a deregulated ECS in the female offspring. The central and peripheral characterization of ECS is a contribution to an understanding of the phenotype observed in this experimental model. Unraveling the associated mechanisms can contribute to the discovery of new pharmacological targets for the treatment of several metabolic diseases originated during development, especially those caused by maternal smoking or caused by the use of nicotine patch by mothers who wish to quit smoking.

Acknowledgments

We thank the Mr. Ulisses Risso Siqueira for animal care and to Mrs. Fabiana Gallaulckydio and Mr. Leandro Fraga Bezerra for technical assistance.

Financial support

This work was supported by Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Conflicts of interest

The authors declare that no conflict of interest.

Ethical standards

All experimental procedures performed in this work are in accordance with the ethical standards of the relevant guides on the care and use of laboratory animals and were approved by the institutional ethics committee of the Institute of Biology of the University of the State of Rio de Janeiro (CEUA/033/2017).

References

Barker, DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004; 23(6 Suppl.), 588S–595S. DOI 10.1080/07315724.2004.10719428.CrossRefGoogle ScholarPubMed
Haugen, AC, Schug, TT, Collman, G, Heindel, JJ. Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis. 2015; 6(2), 55–64. DOI 10.1017/S2040174414000580.CrossRefGoogle ScholarPubMed
Bahadori, B, Riediger, ND, Farrell, SM, Uitz, E, Moghadasian, MF. Hypothesis: smoking decreases breast feeding duration by suppressing prolactin secretion. Med Hypotheses. 2013; 81(4), 582–586. DOI 10.1016/j.mehy.2013.07.007.CrossRefGoogle ScholarPubMed
Horta, BL, Victora, CG, Menezes, AM, Barros, FC. Environmental tobacco smoke and breastfeeding duration. Am J Epidemiol. 1997; 146(2), 128–133. DOI 10.1093/oxfordjournals.aje.a009243.CrossRefGoogle ScholarPubMed
Napierala, M, Mazela, J, Merritt, TA, Florek, E. Tobacco smoking and breastfeeding: effect on the lactation process, breast milk composition and infant development. A critical review. Environ Res. 2016; 151, 321–338. DOI 10.1016/j.envres.2016.08.002.CrossRefGoogle ScholarPubMed
Somm, E, Schwitzgebel, VM, Vauthay, DM, et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology. 2008; 149(12), 6289–6299. DOI 10.1210/en.2008-0361.CrossRefGoogle ScholarPubMed
Marcham, CL, Floyd, EL, Wood, BL, Arnold, S, Johnson, DL. E-cigarette nicotine deposition and persistence on glass and cotton surfaces. J Occup Environ Hyg. 2019; 16(5), 349–354. DOI 10.1080/15459624.2019.1581366.CrossRefGoogle ScholarPubMed
Anastopoulos, I, Pashalidis, I, Orfanos, AG, et al. Removal of caffeine, nicotine and amoxicillin from (waste)waters by various adsorbents. A review. J Environ Manage. 2020; 261, 110236. DOI 10.1016/j.jenvman.2020.110236.CrossRefGoogle ScholarPubMed
Selmar, D, Radwan, A, Abdalla, N, et al. Uptake of nicotine from discarded cigarette butts - a so far unconsidered path of contamination of plant-derived commodities. Environ Pollut. 2018; 238, 972–976. DOI 10.1016/j.envpol.2018.01.113.CrossRefGoogle Scholar
Li, Z, Li, Z, Zhang, J, et al. Using nicotine in scalp hair to assess maternal passive exposure to tobacco smoke. Environ Pollut. 2017; 222, 276–282. DOI 10.1016/j.envpol.2016.12.044.CrossRefGoogle ScholarPubMed
Miranda, RA, Gaspar de Moura, E, Lisboa, PC. Tobacco smoking during breastfeeding increases the risk of developing metabolic syndrome in adulthood: lessons from experimental models. Food Chem Toxicol. 2020; 144, 111623. DOI 10.1016/j.fct.2020.111623.CrossRefGoogle ScholarPubMed
Miranda, RA, de Moura, EG, Soares, PN, et al. Thyroid redox imbalance in adult Wistar rats that were exposed to nicotine during breastfeeding. Sci Rep. 2020; 10(1), 15646. DOI 10.1038/s41598-020-72725-w.CrossRefGoogle ScholarPubMed
Peixoto, TC, Moura, EG, Soares, PN, et al. Nicotine exposure during lactation causes disruption of hedonic eating behavior and alters dopaminergic system in adult female rats. Appetite. 2021; 160, 105115. DOI 10.1016/j.appet.2021.105115.CrossRefGoogle ScholarPubMed
Hillard, CJ. Endocannabinoids and the endocrine system in health and disease. Handb Exp Pharmacol. 2015; 231, 317–339. DOI 10.1007/978-3-319-20825-1_11.CrossRefGoogle ScholarPubMed
Pagotto, U, Marsicano, G, Cota, D, Lutz, B, Pasquali, R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006; 27(1), 73–100. DOI 10.1210/er.2005-0009.CrossRefGoogle ScholarPubMed
Zdanowicz, A, Kazmierczak, W, Wierzbinski, P. [The endocannabinoid system role in the pathogenesis of obesity and depression]. Pol Merkur Lekarski. 2015; 39(229), 61–66. DOI doi.Google ScholarPubMed
Hu, SS, Mackie, K. Distribution of the endocannabinoid system in the central nervous system. Handb Exp Pharmacol. 2015; 231, 59–93. DOI 10.1007/978-3-319-20825-1_3.CrossRefGoogle ScholarPubMed
Ruminska, A, Dobrzyn, A. [The endocannabinoid system and its role in regulation of metabolism in peripheral tissues]. Postepy Biochem. 2012; 58(2), 127–134. DOI doi.Google ScholarPubMed
Zou, S, Kumar, U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018; 19(3 10.3390/ijms19030833.CrossRefGoogle ScholarPubMed
Howlett, AC, Barth, F, Bonner, TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002; 54(2), 161–202. DOI 10.1124/pr.54.2.161.CrossRefGoogle ScholarPubMed
Kilaru, A, Chapman, KD. The endocannabinoid system. Essays Biochem. 2020; 64(3), 485–499. DOI 10.1042/EBC20190086.Google ScholarPubMed
Mechoulam, R, Parker, LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013; 64(1), 21–47. DOI 10.1146/annurev-psych-113011-143739.CrossRefGoogle ScholarPubMed
Quarta, C, Mazza, R, Obici, S, Pasquali, R, Pagotto, U. Energy balance regulation by endocannabinoids at central and peripheral levels. Trends Mol Med. 2011; 17(9), 518–526. DOI 10.1016/j.molmed.2011.05.002.CrossRefGoogle ScholarPubMed
Sanchez-Fuentes, A, Marichal-Cancino, BA, Mendez-Diaz, M, Becerril-Melendez, AL, Ruiz-Contreras, AE, Prospero-Garcia, O. mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system. Neurosci Lett. 2016; 631, 104–108. DOI 10.1016/j.neulet.2016.08.020.CrossRefGoogle ScholarPubMed
Richard, D, Guesdon, B, Timofeeva, E. The brain endocannabinoid system in the regulation of energy balance. Best Pract Res Clin Endocrinol Metab. 2009; 23(1), 17–32. DOI 10.1016/j.beem.2008.10.007.CrossRefGoogle ScholarPubMed
Peterfi, Z, Farkas, I, Denis, RGP, et al. Endocannabinoid and nitric oxide systems of the hypothalamic paraventricular nucleus mediate effects of NPY on energy expenditure. Mol Metab. 2018; 18, 120–133. DOI 10.1016/j.molmet.2018.08.007.CrossRefGoogle ScholarPubMed
Barna, I, Zelena, D, Arszovszki, AC, Ledent, C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci. 2004; 75(24), 2959–2970. DOI 10.1016/j.lfs.2004.06.006.CrossRefGoogle ScholarPubMed
Wang, M, Meng, N, Chang, Y, Tang, W. Endocannabinoids signaling: molecular mechanisms of liver regulation and diseases. Front Biosci (Landmark Ed). 2016; 21(7), 1488–1501. DOI 10.2741/4468.Google ScholarPubMed
Silvestri, C, Ligresti, A, Di Marzo, V. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev Endocr Metab Disord. 2011; 12(3), 153–162. DOI 10.1007/s11154-011-9167-3.CrossRefGoogle ScholarPubMed
Ziegler, CG, Mohn, C, Lamounier-Zepter, V, et al. Expression and function of endocannabinoid receptors in the human adrenal cortex. Horm Metab Res. 2010; 42(2), 88–92. DOI 10.1055/s-0029-1241860.CrossRefGoogle ScholarPubMed
Niederhoffer, N, Hansen, HH, Fernandez-Ruiz, JJ, Szabo, B. Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br J Pharmacol. 2001; 134(6), 1319–1327. DOI 10.1038/sj.bjp.0704359.CrossRefGoogle ScholarPubMed
Porcella, A, Marchese, G, Casu, MA, et al. Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. Eur J Endocrinol. 2002; 147(2), 255–261. DOI 10.1530/eje.0.1470255.CrossRefGoogle ScholarPubMed
Merritt, LL, Martin, BR, Walters, C, Lichtman, AH, Damaj, MI. The endogenous cannabinoid system modulates nicotine reward and dependence. J Pharmacol Exp Ther. 2008; 326(2), 483–492. DOI 10.1124/jpet.108.138321.CrossRefGoogle ScholarPubMed
Gonzalez, S, Cascio, MG, Fernandez-Ruiz, J, Fezza, F, Di Marzo, V, Ramos, JA. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 2002; 954(1), 73–81. DOI 10.1016/s0006-8993(02)03344-9.CrossRefGoogle ScholarPubMed
Castane, A, Valjent, E, Ledent, C, Parmentier, M, Maldonado, R, Valverde, O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology. 2002; 43(5), 857–867. DOI 10.1016/s0028-3908(02)00118-1.CrossRefGoogle Scholar
World Medical, A, American Physiological, S. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002; 283(2), R281–283. DOI 10.1152/ajpregu.00279.2002.Google Scholar
Oliveira, E, Moura, EG, Santos-Silva, AP, et al. Short- and long-term effects of maternal nicotine exposure during lactation on body adiposity, lipid profile, and thyroid function of rat offspring. J Endocrinol. 2009; 202(3), 397–405. DOI 10.1677/JOE-09-0020.CrossRefGoogle Scholar
Ypsilantis, P, Politou, M, Anagnostopoulos, C, Kortsaris, A, Simopoulos, C. A rat model of cigarette smoke abuse liability. Comp Med. 2012; 62(5), 395–399. DOI doi.Google ScholarPubMed
de Oliveira, E, Moura, EG, Santos-Silva, AP, et al. Neonatal nicotine exposure causes insulin and leptin resistance and inhibits hypothalamic leptin signaling in adult rat offspring. J Endocrinol. 2010; 206(1), 55–63. DOI 10.1677/JOE-10-0104.CrossRefGoogle ScholarPubMed
Paxinos, GC, Charles, W. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition, 2006, 6th edn. Elsevier.Google Scholar
Pagotto, U, Vicennati, V, Pasquali, R. The endocannabinoid system and the treatment of obesity. Ann Med. 2005; 37(4), 270–275. DOI 10.1080/07853890510037419.CrossRefGoogle ScholarPubMed
Mazier, W, Saucisse, N, Gatta-Cherifi, B, Cota, D. The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease. Trends Endocrinol Metab. 2015; 26(10), 524–537. DOI 10.1016/j.tem.2015.07.007.CrossRefGoogle ScholarPubMed
Adermark, L, Morud, J, Lotfi, A, Ericson, M, Soderpalm, B. Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine. Addict Biol. 2019; 24(3), 355–363. DOI 10.1111/adb.12598.CrossRefGoogle ScholarPubMed
Pinheiro, CR, Oliveira, E, Trevenzoli, IH, et al. Developmental plasticity in adrenal function and leptin production primed by nicotine exposure during lactation: gender differences in rats. Horm Metab Res. 2011; 43(10), 693–701. DOI 10.1055/s-0031-1285909.Google ScholarPubMed
Di, S, Malcher-Lopes, R, Halmos, KC, Tasker, JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003; 23(12), 4850–4857. DOI doi.CrossRefGoogle ScholarPubMed
Roberts, CJ, Stuhr, KL, Hutz, MJ, Raff, H, Hillard, CJ. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. Pharmacol Biochem Behav. 2014; 117, 17–24. DOI 10.1016/j.pbb.2013.11.026.CrossRefGoogle ScholarPubMed
Farkas, E, Varga, E, Kovacs, B, et al. A glial-neuronal circuit in the median eminence regulates thyrotropin-releasing hormone-release via the endocannabinoid system. iScience. 2020; 23(3), 100921. DOI 10.1016/j.isci.2020.100921.CrossRefGoogle ScholarPubMed
Osei-Hyiaman, D, DePetrillo, M, Pacher, P, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005; 115(5), 1298–1305. DOI 10.1172/JCI23057.CrossRefGoogle ScholarPubMed
Kunos, G, Osei-Hyiaman, D. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol. 2008; 294(5), G1101–1104. DOI 10.1152/ajpgi.00057.2008.CrossRefGoogle ScholarPubMed
Miranda, RA, De Almeida, MM, Rocha, C, et al. Maternal high-fat diet consumption induces sex-dependent alterations of the endocannabinoid system and redox homeostasis in liver of adult rat offspring. Sci Rep. 2018; 8(1), 14751. DOI 10.1038/s41598-018-32906-0.CrossRefGoogle ScholarPubMed
Conceicao, EP, Peixoto-Silva, N, Pinheiro, CR, Oliveira, E, Moura, EG, Lisboa, PC. Maternal nicotine exposure leads to higher liver oxidative stress and steatosis in adult rat offspring. Food Chem Toxicol. 2015; 78, 52–59. DOI 10.1016/j.fct.2015.01.025.CrossRefGoogle ScholarPubMed
Bertasso, IM, Pietrobon, CB, Lopes, BP, et al. Programming of hepatic lipid metabolism in a rat model of postnatal nicotine exposure - sex-related differences. Environ Pollut. 2020; 258, 113781. DOI 10.1016/j.envpol.2019.113781.CrossRefGoogle Scholar
van Eenige, R, van der Stelt, M, Rensen, PCN, Kooijman, S. Regulation of adipose tissue metabolism by the endocannabinoid system. Trends Endocrinol Metab. 2018; 29(5), 326–337. DOI 10.1016/j.tem.2018.03.001.CrossRefGoogle ScholarPubMed
Di Marzo, V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008; 51(8), 1356–1367. DOI 10.1007/s00125-008-1048-2.CrossRefGoogle ScholarPubMed
Peixoto, TC, Moura, EG, Soares, PN, et al. Nicotine exposure during breastfeeding reduces sympathetic activity in brown adipose tissue and increases in white adipose tissue in adult rats: sex-related differences. Food Chem Toxicol. 2020; 140, 111328. DOI 10.1016/j.fct.2020.111328.CrossRefGoogle ScholarPubMed
Janssen, FJ, van der Stelt, M. Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders. Bioorg Med Chem Lett. 2016; 26(16), 3831–3837. DOI 10.1016/j.bmcl.2016.06.076.CrossRefGoogle ScholarPubMed
Rouzer, CA, Marnett, LJ. Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev. 2011; 111(10), 5899–5921. DOI 10.1021/cr2002799.CrossRefGoogle ScholarPubMed
Tsuboi, K, Okamoto, Y, Ikematsu, N, et al. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta. 2011; 1811(10), 565–577. DOI 10.1016/j.bbalip.2011.07.009.CrossRefGoogle ScholarPubMed
Newsom, RJ, Garcia, RJ, Stafford, J, et al. Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation. Psychoneuroendocrino. 2020; 113, 104549. DOI 10.1016/j.psyneuen.2019.104549.CrossRefGoogle ScholarPubMed
Surkin, PN, Gallino, SL, Luce, V, Correa, F, Fernandez-Solari, J, De Laurentiis, A. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress. Psychoneuroendocrino. 2018; 87, 131–140. DOI 10.1016/j.psyneuen.2017.10.015.CrossRefGoogle ScholarPubMed
Borowska, M, Czarnywojtek, A, Sawicka-Gutaj, N, et al. The effects of cannabinoids on the endocrine system. Endokrynol Pol. 2018; 69(6), 705–719. DOI 10.5603/EP.a2018.0072.CrossRefGoogle ScholarPubMed
da Veiga, MA, Fonseca Bloise, F, Costa, ESRH, et al. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. J Endocrinol. 2008; 199(2), 235–242. DOI 10.1677/JOE-08-0380.CrossRefGoogle ScholarPubMed
Brown, WH, Gillum, MP, Lee, HY, et al. Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism. Proc Natl Acad Sci U S A. 2012; 109(37), 14966–14971. DOI 10.1073/pnas.1212887109.CrossRefGoogle ScholarPubMed
Riebe, CJ, Hill, MN, Lee, TT, Hillard, CJ, Gorzalka, BB. Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrino. 2010; 35(8), 1265–1269. DOI 10.1016/j.psyneuen.2010.02.008.CrossRefGoogle ScholarPubMed
Almeida, MM, Dias-Rocha, CP, Souza, AS, et al. Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring. Br J Nutr. 2017; 118(10), 788–803. DOI 10.1017/S0007114517002884.CrossRefGoogle Scholar
de Almeida, MM, Dias-Rocha, CP, Reis-Gomes, CF, et al. Maternal high-fat diet up-regulates type-1 cannabinoid receptor with estrogen signaling changes in a sex- and depot- specific manner in white adipose tissue of adult rat offspring. Eur J Nutr. 2020, 10.1007/s00394-020-02318-w.doi:.Google Scholar
Moussa-Tooks, AB, Larson, ER, Gimeno, AF, et al. Long-term aberrations to cerebellar endocannabinoids induced by early-life stress. Sci Rep. 2020; 10(1), 7236. DOI 10.1038/s41598-020-64075-4.CrossRefGoogle ScholarPubMed
Carrillo, B, Collado, P, Diaz, F, Chowen, JA, Perez-Izquierdo, MA, Pinos, H. Physiological and brain alterations produced by high-fat diet in male and female rats can be modulated by increased levels of estradiol during critical periods of development. Nutr Neurosci. 2019; 22(1), 29–39. DOI 10.1080/1028415X.2017.1349574.CrossRefGoogle ScholarPubMed
Soares, PN, Miranda, RA, Peixoto, TC, et al. Cigarette smoke during lactation in rat female progeny: late effects on endocannabinoid and dopaminergic systems. Life Sci. 2019; 232, 116575. DOI 10.1016/j.lfs.2019.116575.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Antibodies used in western blotting

Figure 1

Table 2. ANOVA results regarding nicotine exposure during lactation on endocannabinoid system of the adult offspring

Figure 2

Fig. 1. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the lateral hypothalamus (LH) of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). GAPDH was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. CB1: cannabinoid type-1 receptor; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; GAPDH: glyceraldehyde-3-phosphate 5 dehydrogenase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 3

Fig. 2. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the paraventricular nucleus (PVN) of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). GAPDH was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. CB1: cannabinoid type-1 receptor; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; GAPDH: glyceraldehyde-3-phosphate 5 dehydrogenase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 4

Fig. 3. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the liver of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group, except for NAPE-PLD from males, n = 5 animals from different litters/group. Differences are represented by *, considering p < 0.05, (Student’s t-test); *p = 0.012 (DAGL) and *p = 0.028 (CB1). CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 5

Fig. 4. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the visceral adipose tissue (VAT) of male (a) and female (c) offspring at PND180-day-old. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Differences are represented by **, considering p < 0.01 (Student’s t-test); p = 0.002. CB1: cannabinoid type-1 receptor; CB2: cannabinoid type-2 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 6

Fig. 5. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in the adrenal glands of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Statistical differences are represented by *, considering p < 0.05 (Student’s t-test); p = 0.026. CB1: cannabinoid type-1 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 7

Fig. 6. Effects of nicotine exposure during breastfeeding on the endocannabinoid system in thyroid glands of male (a) and female (c) offspring at PND180. Representative western blot bands for each protein are shown (b; d). Cyclophilin was used as housekeeping gene. Data are expressed as mean ± S.E.M, n = 7 animals from different litters/group. Statistical differences are represented by **, considering p < 0.01 (Student’s t-test); p = 0.006. CB1: cannabinoid type-1 receptor; Cyclo: Cyclophilin; DAGL: diacylglycerol lipase; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D.

Figure 8

Fig. 7. The first panel (a) depicts the main proteins involved in endocannabinoid synthesis and degradation pathways. Phosphatidylethanolamine (PE) is converted to N-acylphosphatidylethanolamine (NAPE), catalyzed by the NAPE-phospholipase D (NAPE-PLD), producing anandamide (AEA). In addition, phosphatidylinositol (PI) is hydrolyzed by phospholipase C (PLC), originating diacylglycerol (DAG), which is converted to 2-arachidonoylglycerol (2-AG) by diacylglycerol lipase (DAGL). The endocannabinoids AEA and 2-AG act by binding to both type-1 or type-2 cannabinoid receptors (CB1 or CB2). The degradation of the endocannabinoids is mediated by fatty acid amide hydrolase (FAAH), which is responsible for AEA degradation, and by monoacylglycerol lipase (MAGL), which is responsible for 2-AG degradation. The metabolites of AEA and 2-AG are the arachidonic acid (AA) and ethanolamine, and AA and glycerol, respectively. The second panel (b) shows the main effects of the endocannabinoids in different tissues. The third panel (c) describes the ECS markers in adult rats that were nicotine-exposed during breastfeeding. OMP: osmotic minipumps.